Article: Cardiac Dimensions(R) Inc. Announces First Implant of CARILLON(TM) Mitral Contour System(TM) for Percutaneous Treatment of Functional Mitral Regurgitation.

KIRKLAND, Wash. -- Professor Joachim Schofer places first CARILLON(TM) implant in Hamburg Germany as part of the AMADEUS(TM) Trial

Cardiac Dimensions(R), Inc. announced today the first human implant of the CARILLON(TM) Mitral Contour System(TM), an investigational device for percutaneous treatment of Functional Mitral Regurgitation (FMR). The procedure was performed in Hamburg Germany by Professor Dr. med. Joachim Schofer -- the principal investigator (PI) of the company's AMADEUS(TM) trial. AMADEUS (cArillon Mitral Annuloplasty Device European Union Study) is a safety and efficacy study of the CARILLON system ongoing at seven centers across Europe. The study will ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!